Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Matrix metalloprotease-7 is associated with post-COVID-19 persistent lung abnormalities.
Buendia-Roldan I, Chavez-Galan L, Aguilar-Duran H, Ruiz A, Falfan-Valencia R, Pérez-Rubio G, Pardo A, Selman M. Buendia-Roldan I, et al. Among authors: aguilar duran h. ERJ Open Res. 2024 Dec 2;10(6):00266-2024. doi: 10.1183/23120541.00266-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39624381 Free PMC article.
Persistence of lung structural and functional alterations at one year post-COVID-19 is associated with increased serum PD-L2 levels and altered CD4/CD8 ratio.
Buendia-Roldan I, Martínez-Espinosa K, Aguirre MJ, Aguilar-Duran H, Palma-Lopez A, Palacios Y, Ruiz A, Ramón-Luing LA, Ocaña-Guzmán R, Pérez-Rubio G, Falfán-Valencia R, Selman M, Chavez-Galan L. Buendia-Roldan I, et al. Among authors: aguilar duran h. Immun Inflamm Dis. 2024 Jul;12(7):e1305. doi: 10.1002/iid3.1305. Immun Inflamm Dis. 2024. PMID: 39031504 Free PMC article.
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population.
Gutiérrez-Pérez IA, Buendía-Roldán I, Pérez-Rubio G, Chávez-Galán L, Hernández-Zenteno RJ, Aguilar-Duran H, Fricke-Galindo I, Zaragoza-García O, Falfán-Valencia R, Guzmán-Guzmán IP. Gutiérrez-Pérez IA, et al. Among authors: aguilar duran h. Front Med (Lausanne). 2022 Oct 21;9:1000147. doi: 10.3389/fmed.2022.1000147. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36341268 Free PMC article.
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
Fricke-Galindo I, Martínez-Morales A, Chávez-Galán L, Ocaña-Guzmán R, Buendía-Roldán I, Pérez-Rubio G, Hernández-Zenteno RJ, Verónica-Aguilar A, Alarcón-Dionet A, Aguilar-Duran H, Gutiérrez-Pérez IA, Zaragoza-García O, Alanis-Ponce J, Camarena A, Bautista-Becerril B, Nava-Quiroz KJ, Mejía M, Guzmán-Guzmán IP, Falfán-Valencia R. Fricke-Galindo I, et al. Among authors: aguilar duran h. Front Immunol. 2022 Jul 29;13:949413. doi: 10.3389/fimmu.2022.949413. eCollection 2022. Front Immunol. 2022. PMID: 35967349 Free PMC article.
Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation.
Chavez-Galan L, Ruiz A, Martinez-Espinosa K, Aguilar-Duran H, Torres M, Falfan-Valencia R, Pérez-Rubio G, Selman M, Buendia-Roldan I. Chavez-Galan L, et al. Among authors: aguilar duran h. Biomolecules. 2022 Mar 14;12(3):445. doi: 10.3390/biom12030445. Biomolecules. 2022. PMID: 35327637 Free PMC article.